| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |